ClinicalTrials.Veeva

Menu

Vitamin D and Staphylococcus Aureus in the Diabetes Study

U

University of Tromso (UiT)

Status and phase

Completed
Phase 3

Conditions

Infection

Treatments

Drug: cholecalciferol

Study type

Interventional

Funder types

Other

Identifiers

NCT01395290
UIT-ENDO-2011-1

Details and patient eligibility

About

There are indications that the vitamin D status of an individual is related to susceptibility to staphylococcal infections. In the present study we will examine nasal colonisation rate in subjects participating in an ongoing vitamin D intervention study ( 20.000 IU cholecalciferol per week vs placebo) for the prevention of type 2 diabetes in subjects with impaired glucose tolerance.

Enrollment

280 patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • participant in an ongoing intervention study with vitamin D

Exclusion criteria

  • none specifically for this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

280 participants in 1 patient group

cholecalciferol
Experimental group
Description:
cholecalciferol 20.000 IU per week
Treatment:
Drug: cholecalciferol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems